NASDAQ · Biotechnology

MeiraGTx Holdings plc (MGTX) Stock

$9.21 -5.73% NASDAQ: MGTX Healthcare

Valuation

MetricValue
Price$9.21
Market Cap$884.56M
P/E Ratio17.43
P/B Ratio5.62
P/S Ratio3.09
EPS (TTM)$-1.42
52-Week High$15.35
52-Week Low$6.62
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE284.38%
ROA19.92%
ROCE-87.60%
Gross Margin-130.86%
Operating Margin-130.86%
Net Margin19.87%
Debt/Equity0.52
Current Ratio0.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$38.0M$16.0M$14.0M$33.0M$81.0M
Operating Profit$-73.0M$-116.0M$-137.0M$-164.0M$-106.0M
Net Profit$-80.0M$-130.0M$-84.0M$-148.0M$-114.0M
EPS$-1.80$-2.87$-1.49$-2.12$-1.42
Op Margin-193.0%-730.9%-977.8%-493.4%-130.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$320.0M$318.0M$327.0M$270.0M$244.0M
Total Liabilities$135.0M$200.0M$189.0M$202.0M$250.0M
Cash$138.0M$116.0M$130.0M$104.0M$66.0M
Borrowings$24.0M$92.0M$89.0M$85.0M$89.0M

Latest News

MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? Zacks · Jul 8, 2026 RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating MT Newswires · Jul 8, 2026 Top Midday Gainers MT Newswires · Jul 7, 2026 MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) GlobeNewswire · Jul 7, 2026 Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint Insider Monkey · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-73.0M$-105.0M$-104.0M$-46.0M
Investing Cash Flow$-117.0M$-90.0M$14.0M$19.0M$-8.0M
Financing Cash Flow$0$-5.0M$-8.0M$-5.0M$-3.0M
Net Cash Flow$-72.0M$-22.0M$15.0M$-25.0M$-37.0M
Free Cash Flow$-66.0M$-118.0M$-126.0M$-109.0M$-50.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.76
EV / EBITDA4.60
FCF Yield-5.61%
Quick Ratio0.75
Interest Coverage-8.83
Return 1Y42.52%
Return 3Y74.60%
Return 5Y-11.40%

Ownership

Insiders Held17.12%
Institutions Held61.14%
Institutions Float Held73.77%
Institutional HolderSharesReport Date
Sanofi12,197,7372026-03-31
Perceptive Advisors Llc10,326,1032026-03-31
Rubric Capital Management LP7,000,0002026-03-31
Johnson & Johnson6,641,0642026-03-31
Adage Capital Partners GP L.L.C.4,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
FDMT4D Molecular Therapeutics, Inc. $10.80 -8.86% -5.03 $596.64M 0.00%
KRYSKrystal Biotech, Inc. $311.50 -2.70% 38.97 $9.22B 0.00%
LCTXLineage Cell Therapeutics, Inc. $1.00 +1.52% -6.61 $252.91M 0.00%
NTLAIntellia Therapeutics, Inc. $11.21 +0.45% -3.65 $1.57B 0.00%
OCGNOcugen, Inc. $0.74 -6.37% -3.09 $250.84M 0.00%

About MeiraGTx Holdings plc

MeiraGTx Holdings plc is led by CEO Alexandria Forbes, employs 375 people, headquartered in US, publicly traded since 2018.

MeiraGTx Holdings plc (MGTX) stock trades at $9.21 with a market capitalization of $884.56M. The stock is valued at a price-to-earnings (P/E) ratio of 17.43, price-to-book of 5.62, price-to-sales of 3.09. Over the past 52 weeks the stock has ranged between $6.62 and $15.35, and currently trades 40.0% below its 52-week high.

On profitability, MeiraGTx Holdings plc generates a return on equity (ROE) of 284.38%, above the typical market range of roughly 12-15%, return on capital employed of -87.60%, an operating margin of -130.86%, a net profit margin of 19.87%.

MeiraGTx Holdings plc by the numbers, 2016–2025

Between 2016 and 2025 MeiraGTx Holdings plc reported revenue of $0 rising to $81.0M. Compounded, revenue has grown 38.3% a year over five years, 71.7% over three, 145.4% over the last twelve months. Net profit fell to $-114.0M.

The most recent net margin is 19.87%. On a trailing twelve-month basis to Jun '26, revenue is $396.0M and net profit $79.0M.

Borrowings stand at $89.0M, cash from operations was $-46.0M in the latest year, positive in 1 of the last 10.

Return on equity has averaged 293.6% over five years, and was 1900.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

MeiraGTx Holdings plc (MGTX) — frequently asked questions

What is MeiraGTx Holdings plc (MGTX) stock price today?

MeiraGTx Holdings plc (MGTX) is currently trading at $9.21, down 5.73% today.

What is MGTX P/E ratio?

MeiraGTx Holdings plc's P/E ratio is 17.43. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is MGTX return on equity (ROE)?

MeiraGTx Holdings plc's return on equity (ROE) is 284.38%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is MeiraGTx Holdings plc's market cap?

MeiraGTx Holdings plc has a market capitalization of $884.56M.

Does MGTX pay a dividend?

MeiraGTx Holdings plc is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does MGTX carry?

MeiraGTx Holdings plc has a debt-to-equity ratio of 0.52. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is MGTX's profit margin?

MeiraGTx Holdings plc reports a net profit margin of 19.87% — the share of revenue left after every cost, including tax and interest.

What sector is MGTX in?

MeiraGTx Holdings plc is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is MGTX listed on?

MeiraGTx Holdings plc trades on NASDAQ under the ticker MGTX.

What is MGTX's 52-week range?

Over the last year MeiraGTx Holdings plc has traded between $6.62 and $15.35.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens MGTX currently matches

On the figures above, MeiraGTx Holdings plc passes the filters for 12 of our ready-made screens, among them Day Losers Stocks, Small Cap Stocks, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Day Losers StocksSmall Cap StocksStocks Under $10Stocks With PE Under 20Stocks Under $100Stocks Under $50Profitable Small Cap StocksStocks With PE Under 25Stocks With PE Under 30High ROE Stocks Under $100Debt to Equity Below 1 StocksNegative Working Capital Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.